Bel Fuse Inc. - BELFB

BELFB Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
BELFB	1.8	2.9	-3.3	21.8	16.5	41.9	501.8	395.5	199.3	715.6
S&P 500	0.3	0.9	2.0	7.1	12.4	31.0	27.4	91.9	188.4	33690.8

Compare BELFB with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	BELFB
name	Bel Fuse Inc.
price	78.54
changes percentage	1.80
change	1.39
day low	77.78
day high	79.48
year high	85.91
year low	45.75
market cap	1026924559
price avg 50	78.37
price avg 200	67.08
exchange	NASDAQ
volume	11255
avg volume	70428
open	77.78
previous close	77.15
eps	4.12
pe	19.06
earnings announcement	2025-02-19T05:00:00.000+0000
shares outstanding	13075179
timestamp	2024-11-22 15:53:28

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 65.3%

Overall Quarterly Financial Health: 37.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000729580
revenue	639813000	654233000	-2.20
gross profit	215849000	183453000	17.66
gross profit ratio	0.34	0.28	20.31
research and development expenses	22487000	20238000	11.11
operating expenses	127873000	112580000	13.58
interest income	0	3379000	-100.00
interest expense	2850000	3379000	-15.66
ebitda	106626000	84788000	25.76
ebitdaratio	0.17	0.1	59.95
operating income	87976000	65147000	35.04
operating income ratio	0.14	0.1	38.09
net income	73831000	52689000	40.13
net income ratio	0.12	0.08	43.28
eps	5.78	3.69	56.64

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 640 million in 2023 from 654 million in 2022 representing a change of -2.2%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 128 million in 2023 from 113 million in 2022 representing a change of 13.58%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 107 million in 2023 from 85 million in 2022 representing a change of 25.76%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 216 million in 2023 from 183 million in 2022 representing a change of 17.66%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 22 million in 2023 from 20 million in 2022 representing a change of 11.11%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 88 million in 2023 from 65 million in 2022 representing a change of 35.04%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 74 million in 2023 from 53 million in 2022 representing a change of 40.13%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 5.78 in 2023 from 5.78 in 2022 representing a change of 56.64%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000729580
revenue	123638000	133205000	-7.18
gross profit	44677000	53396000	-16.33
gross profit ratio	0.36	0.4	-9.85
research and development expenses	5443000	5994000	-9.19
operating expenses	32143000	30135000	6.66
interest income	1480000	1146000	29.14
interest expense	414000	415000	-0.24
ebitda	15238000	26454000	-42.40
ebitdaratio	0.12	0.2	-38.51
operating income	11447000	23261000	-50.79
operating income ratio	0.09	0.17	-46.98
net income	8080000	18806000	-57.03
net income ratio	0.07	0.14	-53.71
eps	0.64	1.53	-58.17

Overall Score of Quarterly Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 124 million in 2024Q3 from 133 million in 2024Q2 representing a change of -7.18%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 45 million in 2024Q3 from 53 million in 2024Q2 representing a change of -16.33%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 5 million in 2024Q3 from 6 million in 2024Q2 representing a change of -9.19%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 32 million in 2024Q3 from 30 million in 2024Q2 representing a change of 6.66%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 15 million in 2024Q3 from 26 million in 2024Q2 representing a change of -42.4%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 11 million in 2024Q3 from 23 million in 2024Q2 representing a change of -50.79%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 0.64 in 2024Q3 from 0.64 in 2024Q2 representing a change of -58.17%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Net Income: Net income increased to 8 million in 2024Q3 from 19 million in 2024Q2 representing a change of -57.03%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000729580
total assets	571631000	560466000	1.99
total liabilities	231073000	298120000	-22.49
total equity	340558000	262346000	29.81
cash and cash equivalents	89371000	70266000	27.19
short term investments	37548000	0	NaN
long term investments	10282000	5539000	85.63
total current assets	381478000	381408000	0.02
total non current assets	190153000	179058000	6.20
total current liabilities	110609000	136304000	-18.85
total non current liabilities	120464000	161816000	-25.55
common stock	1279000	1281000	-0.16
retained earnings	307510000	237188000	29.65
total debt	82586000	116612000	-29.18

Overall Score of Annual Balance Sheet

0.9 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 572 million in 2023 from 560 million in 2022 representing a change of 1.99%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 231 million in 2023 from 298 million in 2022 representing a change of -22.49%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 341 million in 2023 from 262 million in 2022 representing a change of 29.81%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 89 million in 2023 from 70 million in 2022 representing a change of 27.19%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 38 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 381 million in 2023 from 381 million in 2022 representing a change of 0.02%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 111 million in 2023 from 136 million in 2022 representing a change of -18.85%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 308 million in 2023 from 237 million in 2022 representing a change of 29.65%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 83 million in 2023 from 117 million in 2022 representing a change of -29.18%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Common Stock: Common Stock decreased to 1 in 2023 from 1 in 2022 representing a change of -0.16%. This indicates a decrease in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000729580
total assets	584417000	567604000	2.96
total liabilities	217055000	211189000	2.78
total equity	367362000	356415000	3.07
cash and cash equivalents	134266000	84976000	58.00
short term investments	29541000	58822000	-49.78
long term investments	10014000	16739999	-40.18
total current assets	387649000	376021000	3.09
total non current assets	196768000	191583000	2.71
total current liabilities	96887000	89755000	7.95
total non current liabilities	120168000	121434000	-1.04
common stock	1258000	1260000	-0.16
retained earnings	347702000	340462000	2.13
total debt	83259000	82123000	1.38

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 584 million in 2024Q3 from 568 million in 2024Q2 representing a change of 2.96%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 367 million in 2024Q3 from 356 million in 2024Q2 representing a change of 3.07%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 134 million in 2024Q3 from 85 million in 2024Q2 representing a change of 58.0%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 388 million in 2024Q3 from 376 million in 2024Q2 representing a change of 3.09%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 348 million in 2024Q3 from 340 million in 2024Q2 representing a change of 2.13%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 217 million in 2024Q3 from 211 million in 2024Q2 representing a change of 2.78%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 30 million in 2024Q3 from 59 million in 2024Q2 representing a change of -49.78%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 97 million in 2024Q3 from 90 million in 2024Q2 representing a change of 7.95%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 1 in 2024Q3 from 1 in 2024Q2 representing a change of -0.16%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 83 million in 2024Q3 from 82 million in 2024Q2 representing a change of 1.38%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000729580
net change in cash	19105000	8510000	124.50
operating cash flow	108349000	40257000	169.14
free cash flow	96223000	31425000	206.20
capital expenditure	-12126000	-8832000	-37.30
depreciation and amortization	13312000	14863000	-10.44
deferred income tax	-3872000	-4594000	15.72
stock based compensation	3486000	2382000	46.35
accounts payables	-22745000	1522000	-1,594.42
inventory	33613000	-36592000	191.86
acquisitions net	-5219000	1833000	-384.72
investments in property plant and equipment	-12126000	-8832000	-37.30
net cash used for investing activites	-53535000	-6999000	-664.89
debt repayment	-35000000	-17500000	-100.00
common stock issued	0	0	NaN
common stock repurchased	-105000	-349000	69.91
dividends paid	-3492000	-3413000	-2.31
net cash used provided by financing activities	-38597000	-21262000	-81.53
cash at end of period	89371000	70266000	27.19
accounts receivables	27951000	-20702000	235.02
cash at beginning of period	70266000	61756000	13.78

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 19 million in 2023 from 9 million in 2022 representing a change of 124.5%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 108 million in 2023 from 40 million in 2022 representing a change of 169.14%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 96 million in 2023 from 31 million in 2022 representing a change of 206.2%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -12 million in 2023 from -9 million in 2022 representing a change of -37.3%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -4 million in 2023 from -5 million in 2022 representing a change of 15.72%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 3 million in 2023 from 2 million in 2022 representing a change of 46.35%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 23 million in 2023 from 2 million in 2022 representing a change of -1594.42%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 28 in 2023 from -21 million in 2022 representing a change of 235.02%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -3 million in 2023 from -3 million in 2022 representing a change of -2.31%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000729580
operating cash flow	27376000	32194000	-14.97
free cash flow	23748000	30845000	-23.01
capital expenditure	-3628000	-1349000	-168.94
depreciation and amortization	3636000	3439000	5.73
deferred income tax	-2436000	-1254000	-94.26
stock based compensation	1007000	971000	3.71
accounts receivables	6156000	5323000	15.65
accounts payables	724000	3549000	-79.60
inventory	4294000	2284000	88.00
acquisitions net	0	37000	-100.00
investments in property plant and equipment	-3628000	-1349000	-168.94
net cash used for investing activites	25375000	-10375000	344.58
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-1878000	-7892000	76.20
dividends paid	-813000	-837000	2.87
net cash used provided by financing activities	-3021000	-8729000	65.39
net change in cash	49290000	13656000	260.94
cash at end of period	134266000	84976000	58.00
cash at beginning of period	84976000	71320000	19.15

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 49 million in 2024Q3 from 14 million in 2024Q2 representing a change of 260.94%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -4 million in 2024Q3 from -1 million in 2024Q2 representing a change of -168.94%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2024Q3 from 4 million in 2024Q2 representing a change of -79.6%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -1 million in 2024Q3 from -1 million in 2024Q2 representing a change of 2.87%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 27 million in 2024Q3 from 32 million in 2024Q2 representing a change of -14.97%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 24 million in 2024Q3 from 31 million in 2024Q2 representing a change of -23.01%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of 3.71%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 6 in 2024Q3 from 5 million in 2024Q2 representing a change of 15.65%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	50.08	45.85	9.23
net income per share	5.78	3.69	56.50
operating cash flow per share	8.48	2.82	200.60
free cash flow per share	7.53	2.2	241.99
cash per share	9.93	4.92	101.74
book value per share	26.66	18.39	44.99
tangible book value per share	20.7	12.83	61.32
shareholders equity per share	26.66	18.39	44.99
interest debt per share	4.96	6.89	-28.10
market cap	853053520	469746442.36	81.60
enterprise value	846268520	516092442.36	63.98
pe ratio	11.55	8.92	29.60
price to sales ratio	1.33	0.72	85.69
pocfratio	7.87	11.67	-32.53
pfcf ratio	8.87	14.95	-40.69
pb ratio	2.5	1.79	39.89
ptb ratio	2.5	1.79	39.89
ev to sales	1.32	0.79	67.67
enterprise value over ebitda	7.94	6.09	30.39
ev to operating cash flow	7.81	12.82	-39.07
ev to free cash flow	8.79	16.42	-46.45
earnings yield	0.09	0.11	-22.84
free cash flow yield	0.11	0.07	68.61
debt to equity	0.18	0.36	-50.95
debt to assets	0.11	0.17	-37.58
net debt to ebitda	-0.06	0.55	-111.64
current ratio	3.45	2.8	23.25
interest coverage	30.87	19.28	60.11
income quality	1.47	0.76	92.07
dividend yield	0.0	0.01	-43.66
payout ratio	0.05	0.06	-26.98
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.04	0.03	13.62
intangibles to total assets	0.13	0.14	-5.88
capex to operating cash flow	0.11	0.22	-48.99
capex to revenue	0.02	0.01	40.39
capex to depreciation	0.91	0.59	53.29
stock based compensation to revenue	0.01	0.0	49.65
graham number	58.87	39.08	50.64
roic	0.19	0.16	19.54
return on tangible assets	0.15	0.11	36.07
graham net net	2.88	-3.33	186.58
working capital	270869000	245104000	10.51
tangible asset value	264525000	183137000	44.44
net current asset value	150405000	83288000	80.58
invested capital	403916000	382697000	5.54
average receivables	111220000	120464000	-7.67
average payables	52515000	65274500	-19.55
average inventory	154502500	155924000	-0.91
days sales outstanding	55.29	70.03	-21.04
days payables outstanding	34.82	50.08	-30.47
days of inventory on hand	117.55	133.71	-12.09
receivables turnover	6.6	5.21	26.65
payables turnover	10.48	7.29	43.83
inventory turnover	3.11	2.73	13.75
roe	0.22	0.2	7.94
capex per share	0.95	0.62	53.34

• Positive

  ROE: Return on Equity (ROE) increased to 0.22 on 2023-12-31 from 0.20 on 2022-12-31, representing a change of 7.94%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 11.55 on 2023-12-31 from 8.92 on 2022-12-31, representing a change of 29.60%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.18 on 2023-12-31 from 0.36 on 2022-12-31, representing a change of -50.95%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 3.45 on 2023-12-31 from 2.80 on 2022-12-31, representing a change of 23.25%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
BELFB
calendar year	2024	2024	NaN
revenue per share	9.85	10.82	-8.94
net income per share	0.64	1.53	-57.85
operating cash flow per share	2.18	2.61	-16.57
free cash flow per share	1.89	2.51	-24.47
cash per share	13.05	11.68	11.76
book value per share	29.27	28.95	1.12
tangible book value per share	23.47	23.09	1.66
shareholders equity per share	29.27	28.95	1.12
interest debt per share	5.33	5.39	-1.22
market cap	985300500.0	799947737.87	23.17
enterprise value	934293500.0	797094737.87	17.21
pe ratio	30.49	10.63	186.68
price to sales ratio	7.97	6.01	32.70
pocfratio	35.99	24.85	44.85
pfcf ratio	41.49	25.93	59.98
pb ratio	2.68	2.24	19.50
ptb ratio	2.68	2.24	19.50
ev to sales	7.56	5.98	26.28
enterprise value over ebitda	61.31	30.13	103.49
ev to operating cash flow	34.13	24.76	37.84
ev to free cash flow	39.34	25.84	52.24
earnings yield	0.01	0.02	-65.12
free cash flow yield	0.02	0.04	-37.49
debt to equity	0.18	0.19	-2.31
debt to assets	0.11	0.12	-2.20
net debt to ebitda	-3.35	-0.11	-3,003.78
current ratio	4.0	4.19	-4.50
interest coverage	27.65	56.05	-50.67
income quality	3.39	1.71	97.92
dividend yield	0.0	0.0	-21.14
payout ratio	0.1	0.04	126.07
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.04	0.04	-2.17
intangibles to total assets	0.12	0.13	-2.01
capex to operating cash flow	0.13	0.04	216.27
capex to revenue	0.03	0.01	189.75
capex to depreciation	1.0	0.39	154.37
stock based compensation to revenue	0.01	0.01	11.73
graham number	20.59	31.54	-34.71
roic	0.02	0.05	-57.89
return on tangible assets	0.02	0.04	-58.39
graham net net	5.59	5.02	11.28
working capital	290762000	286266000	1.57
tangible asset value	294590000	284285000	3.62
net current asset value	170594000	164832000	3.50
invested capital	423170000	415423000	1.86
average receivables	84184500	89833500	-6.29
average payables	36777000	34616499.5	6.24
average inventory	126408000	129195000	-2.16
days sales outstanding	59.19	58.82	0.62
days payables outstanding	42.33	41.06	3.08
days of inventory on hand	142.34	144.27	-1.33
receivables turnover	1.52	1.53	-0.62
payables turnover	2.13	2.19	-2.99
inventory turnover	0.63	0.62	1.35
roe	0.02	0.05	-58.32
capex per share	0.29	0.11	163.85

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.05 on 2024-06-30 Q2, representing a change of -58.32%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 4.00 on 2024-09-30 Q3 from 4.19 on 2024-06-30 Q2, representing a change of -4.50%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 30.49 on 2024-09-30 Q3 from 10.63 on 2024-06-30 Q2, representing a change of 186.68%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.18 on 2024-09-30 Q3 from 0.19 on 2024-06-30 Q2, representing a change of -2.31%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 50.44 which is lower than current price 78.54, indicates the company may be overvalued.